DTP vaccine

DTP is a combination vaccine against three infectious diseases in humans: diphtheria, tetanus, and polio. This is used in the United Kingdom, the Netherlands, and France.

See also: DPT vaccine
DTP vaccine
Combination of
DiphtheriaVaccine
TetanusVaccine
PolioVaccine
Clinical data
Trade namesREVAXIS
AHFS/Drugs.comUK Drug Information
Routes of
administration		Intramuscular injection
Identifiers
CAS Number
ChemSpider
  • none

Brand names include REVAXIS (Sanofi Pasteur).[1]

By country

In the United Kingdom, DTP is called the "3-in-1 teenage booster" and is given by the NHS to all teenagers aged 14. (The hexavalent vaccine is given to infants and provides the first stage of protection against diphtheria, tetanus, and polio).

In France, DTP is given at 11 months, 11-13 years, then at ages 25, 45, 65, then every ten years.[2]

In the Netherlands, DTP is given as part of the National Immunisation Programme.

References
  1. NHS https://www.nhs.uk/conditions/vaccinations/3-in-1-teenage-booster/
  2. Republique Francaise https://www.service-public.fr/particuliers/vosdroits/F704
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.